Comparability Protocols for Postapproval Changes to the Chemistry, Manufacturing, and Controls Information in an NDA, ANDA, or BLA
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 13, 2022
October 14, 2022
99cef204-366c-4685-b26a-a6a1f744baa3
Related Documents
Identification of Manufacturing Establishments in Applications Submitted to CBER and CDER Questions and Answers
Guidance DocumentOctober 22, 2019Center for Drug Evaluation and Research
Changes to Disposable Manufacturing Materials: Questions and Answers Guidance for Industry
Guidance DocumentJuly 29, 2022Center for Drug Evaluation and Research
CMC Postapproval Manufacturing Changes for Specified Biological Products To Be Documented in Annual Reports
Guidance DocumentDecember 9, 2021Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox